Arrowhead Pharmaceuticals, Inc. (ARWR) compared with its closest peers (HRMY, CORT, EBS, IONS, PCRX). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Harmony Biosciences, Corcept Therapeutics, Emergent BioSolutions, Ionis Pharmaceuticals, Pacira BioSciences, Amphastar Pharmaceuticals, Supernus Pharmaceuticals, Ultragenyx Pharmaceutical, ACADIA Pharmaceuticals and Axsome Therapeutics share Arrowhead Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | $2.22B | 12.3 |
| Corcept Therapeutics Incorporated (CORT) | $13.22B | 42.5 |
| Emergent BioSolutions Inc. (EBS) | $262.37M | 2.3 |
| Ionis Pharmaceuticals, Inc. (IONS) | $9.93B | -33.2 |
| Pacira BioSciences, Inc. (PCRX) | $982.99M | 67.2 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | $952.41M | 15.7 |
| Supernus Pharmaceuticals, Inc. (SUPN) | $2.66B | -73.0 |
| Ultragenyx Pharmaceutical Inc. (RARE) | $2.59B | -3.9 |
| ACADIA Pharmaceuticals Inc. (ACAD) | $5.05B | 13.4 |
| Axsome Therapeutics, Inc. (AXSM) | $10.88B | -49.7 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
ARWR overview · ARWR earnings · ARWR financials · ARWR KPIs · ARWR documents · ARWR ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.